Search This Blog

Tuesday, July 28, 2020

Amgen EPS beats by $0.48, beats on revenue, guidance reaffirmed

Amgen (NASDAQ:AMGN): Q2 Non-GAAP EPS of $4.25 beats by $0.48; GAAP EPS of $3.05 beats by $0.08.
Revenue of $6.21B (+5.8% Y/Y) beats by $20M.
FCF of $2.7B.
FY20 total revenues guidance reaffirmed at $25.0-$25.6B.
Shares +1.9%.
Press Release

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)